AIM: To evaluate the efficacy and safety of the Xiaoyao pill for treatment of functional dyspepsia(FD) associated with perimenopausal depression.METHODS: This was a double-blind, randomized, controlled trial including...AIM: To evaluate the efficacy and safety of the Xiaoyao pill for treatment of functional dyspepsia(FD) associated with perimenopausal depression.METHODS: This was a double-blind, randomized, controlled trial including 180 patients with FD accompanied by depression that were divided into two groups of 90. Patients in the treatment group received oral administration of the Xiaoyao pill for soothing the liver and activating the spleen, and patients in the control group received a placebo. This trial included an 8-wk therapy period with a follow-up period of 6 mo. The total efficacy and degree of depression, as assessed by the Hamilton Rating Scale for Depression(HRSD), were evaluated. Plasma levels of motilin and gastrin were measured and a gastric emptying test was conducted in each participant.RESULTS:The Xiaoyao pill had a good therapeutic effect and improved the symptoms in patients with perimenopausal FD as assessed by the HRSD score,motilin and gastrin levels,and rate of gastric emptying.The total effective rate of the Xiaoyao pill in the treatment group was significantly superior to that of the placebo in the control group.In the control group,the initial HRSD score was 12.12±2.29 and decreased to7.14±1.67 after therapy(P<0.01).In the treatment group,the initial HRSD score was 11.44±2.15,which significantly decreased to 6.20±2.08 after therapy(P<0.01).Moreover,the HRSD score in the treatment group was significantly lower than in control group after 8 wk(P<0.01).Motilin and gastrin levels in both groups were significantly increased after the 8-wk therapy(P<0.05).The gastric emptying rate was also improved in both groups after therapy(P<0.05),and the improvement was significantly better in the treatment group compared to the controls(P<0.05).These results confirm the therapeutic effects of the Xiaoyao pill in perimenopausal FD patients and indicate that it is worthy of clinical promotion.CONCLUSION:The Xiaoyao pill is effective and safe for the treatment of perimenopausal women with FD associated with depression.展开更多
OBJECTIVE:To investigate the effectiveness and safety of Jiawei Xiaoyao pill(加味逍遥丸,JXP)in the treatment of symptoms associated with premenstrual syndrome(PMS).METHODS:A total of 144 regularly menstruating women w...OBJECTIVE:To investigate the effectiveness and safety of Jiawei Xiaoyao pill(加味逍遥丸,JXP)in the treatment of symptoms associated with premenstrual syndrome(PMS).METHODS:A total of 144 regularly menstruating women with PMS were recruited at 8 sites in China from August 2017 to December 2018,and randomized to receive either a JXP or a matching placebo(12 g/d,6 g twice a day)for 3 menstrual cycles.The primary indicator was the reduced Daily Record of Severity of Problems(DRSP)scores in the luteal phase after 3 months of treatment.The safety outcomes included clinical adverse events(AEs),adverse reactions(ARs),changes in vital signs,and laboratory tests.RESULTS:JXP surpassed the placebo in reducing DRSP scores(psychological/somatic dysfunction)in the luteal phase over 3 menstrual cycles of treatment(PFAS=0.002,PPPS=0.001).Additionally,there were no significant differences in the incidence of AEs,severe AEs,withdrawal due to AEs and ARs between the two groups(all P>0.05),and no clinically significant adverse medical events related to the test drug observed.CONCLUSIONS:JXP was superior to the placebo in relieving the symptoms associated with PMS,which signified that JXP may be effective,safe,and welltolerated as an alternative therapy.展开更多
Objective: To investigate the effects of 50% ethyl alcohol (EtOH) extracts from Danzhi Xiaoyao Pill (丹栀逍遥丸, DXP) on the proliferation of MCF-7 human breast cancer cells and potential mechanisms. Methods: AT...Objective: To investigate the effects of 50% ethyl alcohol (EtOH) extracts from Danzhi Xiaoyao Pill (丹栀逍遥丸, DXP) on the proliferation of MCF-7 human breast cancer cells and potential mechanisms. Methods: ATP-Lite assay was performed to test the proliferation of the MCF-7 breast cancer cell line; and antioxidant activity was measured by the oxygen radical absorbance capacity (ORAC). The effects of DXP on nitric oxide (NO) production were tested by lipopolysaccharide (LPS)- stimulated RAW 264.7 murine macrophages using the Griess reaction. Results: The 50% EtOH DXP extracts displayed a cytotoxic response on MCF-7 cells at 0.10, 0.25 and 0.50 mg/mL dosedependently with the proliferation inhibited by more than 85%. The ORAC value of the DXP was 820μ moL Trolox equivalent/g, about 40% of the vitamin C value. DXP extracts had significant inhibitory effect on NO production at the concentration from 0.0625 mg/mL to 0.5 mg/mL (P〈0.05, P〈0.01). Conclusion: The extracts of DXP could significantly inhibit the proliferation of MCF-7 cells, with the effect possibly related to its antioxidant activity and the inhibition of NO production.展开更多
基金Supported by A grant from the National Physical Science Major Project,No.81230087
文摘AIM: To evaluate the efficacy and safety of the Xiaoyao pill for treatment of functional dyspepsia(FD) associated with perimenopausal depression.METHODS: This was a double-blind, randomized, controlled trial including 180 patients with FD accompanied by depression that were divided into two groups of 90. Patients in the treatment group received oral administration of the Xiaoyao pill for soothing the liver and activating the spleen, and patients in the control group received a placebo. This trial included an 8-wk therapy period with a follow-up period of 6 mo. The total efficacy and degree of depression, as assessed by the Hamilton Rating Scale for Depression(HRSD), were evaluated. Plasma levels of motilin and gastrin were measured and a gastric emptying test was conducted in each participant.RESULTS:The Xiaoyao pill had a good therapeutic effect and improved the symptoms in patients with perimenopausal FD as assessed by the HRSD score,motilin and gastrin levels,and rate of gastric emptying.The total effective rate of the Xiaoyao pill in the treatment group was significantly superior to that of the placebo in the control group.In the control group,the initial HRSD score was 12.12±2.29 and decreased to7.14±1.67 after therapy(P<0.01).In the treatment group,the initial HRSD score was 11.44±2.15,which significantly decreased to 6.20±2.08 after therapy(P<0.01).Moreover,the HRSD score in the treatment group was significantly lower than in control group after 8 wk(P<0.01).Motilin and gastrin levels in both groups were significantly increased after the 8-wk therapy(P<0.05).The gastric emptying rate was also improved in both groups after therapy(P<0.05),and the improvement was significantly better in the treatment group compared to the controls(P<0.05).These results confirm the therapeutic effects of the Xiaoyao pill in perimenopausal FD patients and indicate that it is worthy of clinical promotion.CONCLUSION:The Xiaoyao pill is effective and safe for the treatment of perimenopausal women with FD associated with depression.
文摘OBJECTIVE:To investigate the effectiveness and safety of Jiawei Xiaoyao pill(加味逍遥丸,JXP)in the treatment of symptoms associated with premenstrual syndrome(PMS).METHODS:A total of 144 regularly menstruating women with PMS were recruited at 8 sites in China from August 2017 to December 2018,and randomized to receive either a JXP or a matching placebo(12 g/d,6 g twice a day)for 3 menstrual cycles.The primary indicator was the reduced Daily Record of Severity of Problems(DRSP)scores in the luteal phase after 3 months of treatment.The safety outcomes included clinical adverse events(AEs),adverse reactions(ARs),changes in vital signs,and laboratory tests.RESULTS:JXP surpassed the placebo in reducing DRSP scores(psychological/somatic dysfunction)in the luteal phase over 3 menstrual cycles of treatment(PFAS=0.002,PPPS=0.001).Additionally,there were no significant differences in the incidence of AEs,severe AEs,withdrawal due to AEs and ARs between the two groups(all P>0.05),and no clinically significant adverse medical events related to the test drug observed.CONCLUSIONS:JXP was superior to the placebo in relieving the symptoms associated with PMS,which signified that JXP may be effective,safe,and welltolerated as an alternative therapy.
文摘Objective: To investigate the effects of 50% ethyl alcohol (EtOH) extracts from Danzhi Xiaoyao Pill (丹栀逍遥丸, DXP) on the proliferation of MCF-7 human breast cancer cells and potential mechanisms. Methods: ATP-Lite assay was performed to test the proliferation of the MCF-7 breast cancer cell line; and antioxidant activity was measured by the oxygen radical absorbance capacity (ORAC). The effects of DXP on nitric oxide (NO) production were tested by lipopolysaccharide (LPS)- stimulated RAW 264.7 murine macrophages using the Griess reaction. Results: The 50% EtOH DXP extracts displayed a cytotoxic response on MCF-7 cells at 0.10, 0.25 and 0.50 mg/mL dosedependently with the proliferation inhibited by more than 85%. The ORAC value of the DXP was 820μ moL Trolox equivalent/g, about 40% of the vitamin C value. DXP extracts had significant inhibitory effect on NO production at the concentration from 0.0625 mg/mL to 0.5 mg/mL (P〈0.05, P〈0.01). Conclusion: The extracts of DXP could significantly inhibit the proliferation of MCF-7 cells, with the effect possibly related to its antioxidant activity and the inhibition of NO production.